$4.02 Billion Growth in Liquid Biopsy Market During 2020-2024 | Featuring ANGLE Plc and Biocept Inc. Among Others | Technavio

LONDON–(BUSINESS WIRE)–Feb 4, 2021–
Global liquid biopsy market will grow by USD 4.02 billion during 2020-2024.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210204005734/en/
Technavio has announced its latest market research report titled Global Liquid Biopsy Market 2020-2024 (Graphic: Business Wire)
Amid the COVID-19 pandemic the global liquid biopsy market registered a YOY growth of 30.45% in 2020 and the market is estimated to expand at a CAGR of almost 38% during the forecast period. The report offers a detailed analysis of the impact of the COVID-19 pandemic on the market in optimistic, probable, and pessimistic forecast scenarios.
For the Right Perspective & Competitive Insights –Get a Free Sample Report Delivered Instantly
The 120-page report analyzes the liquid biopsy market technology (CTC and ctDNA and exosome and RNA) and geography (Asia, Europe, North America, and ROW). The report offers competitive intelligence about market leaders, key industry opportunities, trends, and threats impacting the growth of the market. Also, the report includes information on marketing, brand, strategy and market development, sales, and supply functions. Download Our Free Sample Report to Know More
The liquid biopsy market is driven by the increasing funding for liquid biopsy. In addition, the rise in the prevalence of cancer cases in the older population is anticipated to boost the growth of the liquid biopsy market.
Over the years, liquid biopsy has increasingly become popular both as a research tool and as a sophisticated diagnostics technology. This is attracting investments and funding for the R&D of new liquid biopsy products. For instance, in May 2019, blood-based cancer detection firm Thrive Earlier Detection announced to have received a USD 110 million funding for R&D in liquid biopsy. Similarly, in May 2017, Guardant Health secured a USD 360 million in investor financing led by SoftBank Group, along with other investors such as Khosla Ventures and Sequoia Capital that had previously funded Guardant Health. Such fundings and investments in the R&D of liquid biopsy products are expected to foster the growth of the market during the forecast period.
Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free.
View market snapshot before purchasing
Major Five Liquid Biopsy Companies:
ANGLE Plc
ANGLE Plc operates its business through the Unified segment. The company offers Parsortix system. It is used for CTC capture, for both epithelial and mesenchymal phenotypes, alongside antibodies for identification of the full range of cancer cells, and bioview imaging solutions for detection and enumeration of the CTCs.
Biocept Inc.
Biocept Inc. operates its business through the Unified segment. Target Selector liquid biopsy. It is a patented platform that helps to characterize tumor cells and evaluate changes in protein expression. The company also offers EmpowerTC. The product offers cancer biomarker testing by using CTC and ctDNA.
Bio-Techne Corp.
Bio-Techne Corp. operates its business through segments such as Protein Sciences and Diagnostics and Genomics. The company offers liquid biopsy tests such as ExoDx Prostate or EPI and ExoDx Lung.
CIRCULOGENE
CIRCULOGENE operates its business through the Unified segment. The company offers Liquid Biopsy test. It combines droplet volumes of blood and NGS to detect known tumor-mutant DNA within cancer-associated genes present in diagnosed cancer patients.
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. operates its business through segments such as Pharmaceuticals and Diagnostics. The company offers cobas EGFR Mutation Test v2 and AVENIO ctDNA Analysis kits.
Register for a free trial today and gain instant access to 17,000+ market research reports.
Technavio’s SUBSCRIPTION platform
Liquid Biopsy Market Technology Outlook (Revenue, USD Billion, 2019-2024)

  • CTC and ctDNA – size and forecast 2019-2024
  • Exosome and RNA – size and forecast 2019-2024

Liquid Biopsy Market Geography Outlook (Revenue, USD Billion, 2019-2024)

  • North America – size and forecast 2019-2024
  • Europe – size and forecast 2019-2024
  • Asia – size and forecast 2019-2024
  • ROW – size and forecast 2019-2024

Are you a start-up willing to make it big in the business? Grab an exclusive Report
Related Reports on Health Care Include:
Global Prostate Biopsy Market – Global prostate biopsy market is segmented by product (prostate needle biopsy and prostate liquid biopsy), end-user (hospitals, ASCs, and diagnostic centers), and geography (North America, Europe, Asia, and ROW). Click Here to Get an Exclusive Free Sample Report
Global Breast Biopsy Devices Market – Global breast biopsy devices market is segmented by product (biopsy needles and systems, biopsy image-guided systems, and others), end-user (hospitals, ASCs, breast cancer specialty centers and clinics, and others), modality (stereotactic X-ray guided breast biopsy, ultrasound-guided breast biopsy, and MRI-guided breast biopsy), and geography (Asia, Europe, North America, and ROW). Click Here to Get an Exclusive Free Sample Report
About Technavio
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
View source version on businesswire.com:https://www.businesswire.com/news/home/20210204005734/en/
CONTACT: Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email:media@technavio.com
Website:www.technavio.com/
KEYWORD:
INDUSTRY KEYWORD: HOSPITALS HEALTH ONCOLOGY MEDICAL DEVICES
SOURCE: Technavio Research
Copyright Business Wire 2021.
PUB: 02/04/2021 09:34 AM/DISC: 02/04/2021 09:34 AM
http://www.businesswire.com/news/home/20210204005734/en